© 2026 Optics and Photonics at Nottingham
43%
56.3%
8.8%
£5m+
Data for 2020-2025 from SciVal
Mahmoud, Rinad; Ordóñez-Morán, Paloma; Allegrucci, Cinzia
Challenges for Triple Negative Breast Cancer treatment: Defeating heterogeneity and cancer stemness Journal Article
In: Cancers (Basel), vol. 14, no. 17, pp. 4280, 2022.
Abstract | Tags: Differentiation, drug resistance, persister cells, phenotype, stemness, triple negative breast cancer, tumour heterogeneity
@article{Mahmoud2022-ls,
title = {Challenges for Triple Negative Breast Cancer treatment:
Defeating heterogeneity and cancer stemness},
author = {Rinad Mahmoud and Paloma Ord\'{o}\~{n}ez-Mor\'{a}n and Cinzia Allegrucci},
year = {2022},
date = {2022-09-01},
journal = {Cancers (Basel)},
volume = {14},
number = {17},
pages = {4280},
publisher = {MDPI AG},
abstract = {The Triple Negative Breast Cancer (TNBC) subtype is known to
have a more aggressive clinical course compared to other breast
cancer subtypes. Targeted therapies for this type of breast
cancer are limited and patients are mostly treated with
conventional chemo- and radio-therapies which are not specific
and do not target resistant cells. Therefore, one of the major
clinical challenges is to find compounds that target the
drug-resistant cell populations which are responsible for
reforming secondary tumours. The molecular profiling of the
different TNBC subtypes holds a promise for better defining
these resistant cells specific to each tumour. To this end, a
better understanding of TNBC heterogeneity and cancer stemness
is required, and extensive genomic analysis can help to
understand the disease complexity and distinguish new molecular
drivers that can be targeted in the clinics. The use of
persister cancer cell-targeting therapies combined with other
therapies may provide a big advance to improve TNBC patients'
survival.},
keywords = {Differentiation, drug resistance, persister cells, phenotype, stemness, triple negative breast cancer, tumour heterogeneity},
pubstate = {published},
tppubtype = {article}
}
Carroll, Christopher Paul; Bolland, Hannah; Vancauwenberghe, Eric; Collier, Pamela; Ritchie, Alison A; Clarke, Philip A; Grabowska, Anna M; Harris, Adrian L; McIntyre, Alan
Targeting hypoxia regulated sodium driven bicarbonate transporters reduces triple negative breast cancer metastasis Journal Article
In: Neoplasia, vol. 25, pp. 41–52, 2022.
Abstract | Tags: EMT, Hypoxia, Metastasis, NDBT, triple negative breast cancer, Tumour Acidosis
@article{Carroll2022-fd,
title = {Targeting hypoxia regulated sodium driven bicarbonate
transporters reduces triple negative breast cancer metastasis},
author = {Christopher Paul Carroll and Hannah Bolland and Eric Vancauwenberghe and Pamela Collier and Alison A Ritchie and Philip A Clarke and Anna M Grabowska and Adrian L Harris and Alan McIntyre},
year = {2022},
date = {2022-03-01},
journal = {Neoplasia},
volume = {25},
pages = {41\textendash52},
publisher = {Elsevier BV},
abstract = {Regions of low oxygen (hypoxia) are found in \>50% of breast
tumours, most frequently in the more aggressive triple negative
breast cancer subtype (TNBC). Metastasis is the cause of 90% of
breast cancer patient deaths. Regions of tumour hypoxia tend to
be more acidic and both hypoxia and acidosis increase tumour
metastasis. In line with this the metastatic process is
dependent on pH regulatory mechanisms. We and others have
previously identified increased hypoxic expression of Na+ driven
bicarbonate transporters (NDBTs) as a major mechanism of tumour
pH regulation. Hypoxia induced the expression of NDBTs in TNBC,
most frequently SLC4A4 and SLC4A5. NDBT inhibition (S0859) and
shRNA knockdown suppressed migration (40% reduction) and
invasion (70% reduction) in vitro. Tumour xenograft metastasis
in vivo was significantly reduced by NDBT knockdown. To
investigate the mechanism by which NDBTs support metastasis, we
investigated their role in regulation of phospho-signalling,
epithelial-to-mesenchymal transition (EMT) and metabolism. NDBT
knockdown resulted in an attenuation in hypoxic
phospho-signalling activation; most notably LYN (Y397) reduced
by 75%, and LCK (Y394) by 72%. The metastatic process is
associated with EMT. We showed that NDBT knockdown inhibited
EMT, modulating the expression of key EMT transcription factors
and ablating the expression of vimentin whilst increasing the
expression of E-cadherin. NDBT knockdown also altered metabolic
activity reducing overall ATP and extracellular lactate levels.
These results demonstrate that targeting hypoxia-induced NDBT
can be used as an approach to modulate phospho-signalling, EMT,
and metabolic activity and reduce tumour migration, invasion,
and metastasis in vivo.},
keywords = {EMT, Hypoxia, Metastasis, NDBT, triple negative breast cancer, Tumour Acidosis},
pubstate = {published},
tppubtype = {article}
}
A part of the University of Nottingham
© 2026 Optics and Photonics at Nottingham. Created for free using WordPress and Kubio